Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

By M. Krampera, L. Cosmi, R. Angeli, A. Pasini, F. Liotta, A. Andreini, V. Santarlasci, B. Mazzinghi, G. Pizzolo, F. Vinante and 4 more. Stem Cells, 2006

646 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/713149be28237b393ac0d2a2dd4ac8df7c5b304d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Angelo S. Mao
2. David J. Mooney
3. Aline M. Betancourt
4. Ruth S. Waterman
5. Suzanne L. Tomchuck
6. Sarah L. Henkle
7. Maria Ester Bernardo

Citations in the corpus

• Regenerative medicine: Current therapies and future directions (2015, background): “For example, MSCs can inhibit T-cell proliferation and dampen inflammation, and this effect is believed to at least partially depend on direct contact of the transplanted MSCs with host immune cells (104).”
• A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype (2010, methodology): “2/CD86, CD40, or CD40L), and can be induced to express MHC class II and Fas ligand only upon interferon treatment [3,32].”